Clinical News

Clinical Research
News & Careers

Search the Site

NEWSLETTERS
FREE Newsletters
Archive

NEWS
News by Subject
News by Date
Search News

CAREER NETWORK
Today's Hot Jobs
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

PROFILES
Company Profiles

INDUSTRY EVENTS
Clinical

RESOURCES
Real Estate
New Business Opportunities

News | News By Subject | News By Date | Search News

News By Date

Tuesday, May 13, 2008

Top Breaking News

Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials More...

SGX Pharmaceuticals, Inc. (SGXP) Discontinued Development of SGX523; Announces First Quarter Financial Results More...

FDA Approves Warner Chilcott's Taclonex Scalp(R), Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis More...

FDA Approves Novo Nordisk, Inc. (NVO)'s NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors More...

Hollis-Eden Pharmaceuticals Inc. (HEPH) Provides Update on Clinical Development Programs; Announces First Quarter 2008 Financial Results More...

Featured Stories

Pfizer Inc. (PFE)'s Celebrex Doesn't Prevent Memory Loss in the Elderly; Anti-Inflammatories Did Not Ward Off Dementia, Pfizer Inc. (PFE) Study More...

AstraZeneca PLC (AZN)'s Toprol Raises Risk of Death, McMaster University Study More...

Drugs for Restless Legs Syndrome Have Downsides, University of Connecticut Study More...

Flu Vaccine Makers To Set New Doses Record For Next Season, CSL Biotherapies, Sanofi Pasteur (SASY.PA), Novartis Vaccines and Diagnostics, GlaxoSmithKline (GSK), and MedImmune Vaccines More...

Pfizer Inc. (PFE)’s Viagra May Help Heart In Muscular Dystrophy, Université de Montréal, Montreal Heart Institute, McGill University, and Institut de Recherches Cliniques de Montréal Study More...

Drug Company Executives from Johnson & Johnson (JNJ), Pfizer Inc. (PFE), and a joint-venture between Merck & Co., Inc. (MRK) and Schering-Plough Corporation (SGP) Respond To Concerns About Ads At House Panel Hearing More...

Marijuana May Up Heart Attack Or Stroke Risk, National Institutes of Health (NIH) Study More...

Medical Research Should Include More Women Participants And Examine The Role Of Gender In Disease, Mayo Clinic Study More...

More News

Valeant Pharmaceuticals International (VRX) Announces Successful Completion of Retigabine Phase III Epilepsy Program Validating Novel Mechanism of Action More...

Active Biotech AB Advances ANYARA into Phase III Clinical Trial More...

Bioniche Life Sciences Inc. (BNC.TO) Provides Update on Mycobacterial Cell Wall Technology Platform More...

ALSERES Pharmaceuticals, Inc. (ALSE) Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial More...

Medarex, Inc. (MEDX) Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis More...

Crucell N.V. (CRXL) Release: Start of Phase II Clinical Study for Rabies Monoclonal Antibody Combination in the Philippines More...

ImClone Systems Incorporated (IMCL) Release: Phase II Study of IMC-A12 for Advanced Liver Cancer Opens for Patient Enrollment More...

NicOx SA (NCOX.F) Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-donating Agent in Hypertensive Patients by Merck & Co., Inc. (MRK) More...

AVI BioPharma, Inc. (AVII) Announces Significant Advance in the Potential Treatment of Ebola and Marburg Virus Infections More...

PRANA Biotechnology (PRAN) Announces PNAS Publication Describing New Class of Anti-Amyloid Drugs More...